retatrutide gip glp-1 glucagon receptor agonist Retatrutide, a GIP, and agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA retatrutide triple agonist glp-1 gip

GLP-1 medications may offer benefits beyond weight loss and diabetes management, including better outcomes for breast cancer patients who are obese or have type 2 diabetes, according to new research.

Ron Grisanti, D.C., D.A.B.C.O., D.A.C.B.N., M.S., DIANM, CFMP is the founder of Functional Medicine University and author of The Medical Detective Reports. Read his full bio ...

Science-backed supplements redefine health, weight loss, and vitality

AJMC, 18 January 2021: [11] Digital health companies making a long-term play for the $100B weight loss drug market

Low Acid High Antioxidant Coffee for those who love the great taste of high quality coffee but suffer from Heartburn, Acid Reflux, GERD, IC, or IBS

Servings Per Container: 30